BREAKING NEWS

BREAKING NEWS

Johnson & Johnson seeks full control of Crucell

Now Reading:

Johnson & Johnson seeks full control of Crucell

Johnson & Johnson seeks full control of Crucell
Text size Aa Aa

US healthcare giant Johnson and Johnson is talking to Dutch biotech company Crucell about buying the shares in the firm it does not already own for 1.75 billion euros.

Johnson and Johnson wants to strengthen its vaccine business, and is offering a 58 percent premium on the share price. Crucell is one of only two major independent vaccine makers in Europe, the other being Austria’s Intercell.